Macakurzin C Derivatives as a Novel Pharmacophore for Pan-Peroxisome Proliferator-Activated Receptor Modulatoropen access
- Authors
- Ko, Hyejin; An, Seungchan; Jang, Hongjun; Ahn, Sungjin; Park, In Guk; Hwang, Seok Young; Gong, Junpyo; Oh, Soyeon; Kwak, Soo Yeon; Choi, Won Jun; Kim, Hyoungsu; Noh, Minsoo
- Issue Date
- May-2023
- Publisher
- 한국응용약물학회
- Keywords
- Macakurzin C derivative; Peroxisome proliferator-activated receptor; Adiponectin; Human bone marrow mesenchymal stem cells; PPARa/? dual modulator
- Citation
- Biomolecules & Therapeutics, v.31, no.3, pp 312 - 318
- Pages
- 7
- Indexed
- SCIE
SCOPUS
KCI
- Journal Title
- Biomolecules & Therapeutics
- Volume
- 31
- Number
- 3
- Start Page
- 312
- End Page
- 318
- URI
- https://scholarworks.dongguk.edu/handle/sw.dongguk/19914
- DOI
- 10.4062/biomolther.2022.097
- ISSN
- 1976-9148
2005-4483
- Abstract
- The natural flavonoid macakurzin C (1) exhibited adiponectin biosynthesis-inducing activity during adipogenesis in human bone marrow mesenchymal stem cells and its molecular mechanism was directly associated with a pan-peroxisome proliferator-activat-ed receptor (PPAR) modulator affecting all three PPAR subtypes a, ?, and 6. In this study, increases in adiponectin biosynthesis -inducing activity by macakurzin C derivatives (2-7) were studied. The most potent adiponectin biosynthesis-inducing compound 6, macakurzin C 3,5-dimethylether, was elucidated as a dual PPARa/? modulator. Compound 6 may exhibit the most potent activity because of the antagonistic relationship between PPAR6 and PPAR?. Docking studies revealed that the O-methylation of macakurzin C to generate compound 6 significantly disrupted PPAR6 binding. Compound 6 has therapeutic potential in hypoadi-ponectinemia-related metabolic diseases.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Pharmacy > Department of Pharmacy > 1. Journal Articles

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.